UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC cut its stake in Maximus, Inc. (NYSE:MMS – Free Report) by 41.1% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 110,200 shares of the health services provider’s stock after selling 76,881 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Maximus were worth $5,924,000 at the end of the most recent quarter.
A number of other institutional investors have also recently modified their holdings of the stock. BlackRock Inc. bought a new position in shares of Maximus in the second quarter worth $400,186,000. Reinhart Partners LLC. lifted its position in Maximus by 131.8% during the second quarter. Reinhart Partners LLC. now owns 1,982,415 shares of the health services provider’s stock worth $106,575,000 after purchasing an additional 1,127,346 shares during the period. Norges Bank acquired a new stake in Maximus during the fourth quarter worth about $60,393,000. Bank of America Corp DE acquired a new stake in Maximus during the second quarter worth about $31,487,000. Finally, River Road Asset Management LLC increased its holdings in Maximus by 236.1% in the 4th quarter. River Road Asset Management LLC now owns 823,262 shares of the health services provider’s stock valued at $71,064,000 after buying an additional 578,326 shares during the period. 97.21% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
Several brokerages have recently commented on MMS. Zacks Research cut shares of Maximus from a “hold” rating to a “strong sell” rating in a research report on Tuesday, August 11th. Weiss Ratings reissued a “hold (c-)” rating on shares of Maximus in a research note on Monday, August 17th. Finally, Wall Street Zen downgraded shares of Maximus from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Reduce”.
Maximus Stock Performance
Maximus stock opened at $56.37 on Wednesday. The company has a quick ratio of 2.42, a current ratio of 2.42 and a debt-to-equity ratio of 0.90. The stock has a market cap of $2.95 billion, a PE ratio of 8.33 and a beta of 0.59. Maximus, Inc. has a 12-month low of $52.73 and a 12-month high of $100.00. The business’s 50-day moving average price is $58.03 and its two-hundred day moving average price is $62.69.
Maximus (NYSE:MMS – Get Free Report) last posted its earnings results on Thursday, August 6th. The health services provider reported $2.22 EPS for the quarter, topping analysts’ consensus estimates of $2.21 by $0.01. The firm had revenue of $1.28 billion during the quarter, compared to analysts’ expectations of $1.33 billion. Maximus had a net margin of 7.07% and a return on equity of 24.91%. The business’s revenue for the quarter was down 5.1% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.16 earnings per share. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. As a group, analysts expect that Maximus, Inc. will post 8.03 earnings per share for the current fiscal year.
Maximus Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Monday, August 31st. Shareholders of record on Friday, August 14th were paid a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date of this dividend was Friday, August 14th. Maximus’s payout ratio is presently 19.50%.
Maximus Profile
Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.
Featured Stories
- Five stocks we like better than Maximus
- Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected
- Despite Post-Earnings Drop, Wall Street Analysts Eye New Highs for Broadcom Stock
- Morgan Stanley Eyes Good Things Ahead for Meta After $18 Billion Legal Settlement
- Q3 Earnings Could Be the Catalyst the Market Has Been Waiting For
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS – Free Report).
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.
